ProKidney Corp.
PROK
$1.75
-$0.03-1.69%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.69% | -1.81% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.69% | -1.81% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 3.69% | -1.81% | |||
| SG&A Expenses | 1.21% | -17.30% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 19.45% | -3.74% | |||
| Operating Income | -19.54% | 3.75% | |||
| Income Before Tax | -20.28% | 2.31% | |||
| Income Tax Expenses | -383.04% | -33.96% | |||
| Earnings from Continuing Operations | -13.97% | 3.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 11.60% | -5.09% | |||
| Net Income | -16.77% | 0.50% | |||
| EBIT | -19.54% | 3.75% | |||
| EBITDA | -19.98% | 4.43% | |||
| EPS Basic | -11.80% | 3.63% | |||
| Normalized Basic EPS | -96.74% | -11.52% | |||
| EPS Diluted | -11.80% | 3.63% | |||
| Normalized Diluted EPS | -96.74% | -11.52% | |||
| Average Basic Shares Outstanding | 4.45% | 3.26% | |||
| Average Diluted Shares Outstanding | 4.45% | 3.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||